Glycolytic Metabolism Plays a Functional Role in Regulating Human Pluripotent Stem Cell State

Cell Stem Cell

Volumn 19, Issue 4, 2016, Pages 476-490

  Gu, Wen ^a   Gaeta, Xavier ^b   Sahakyan, Anna ^a,b   Chan, Alanna B ^a   Hong, Candice S ^a   Kim, Rachel ^b   Braas, Daniel ^a,b   Plath, Kathrin ^a,b   Lowry, William E ^a,b   Christofk, Heather R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MONOCARBOXYLATE TRANSPORTER 1; MYC PROTEIN; COTRANSPORTER; MONOCARBOXYLATE TRANSPORT PROTEIN 1; MONOCARBOXYLATE TRANSPORTER; N MYC PROTO ONCOGENE PROTEIN;

ARTICLE; BLASTOCYST; CELL FATE; CELL GROWTH; CELL LINEAGE; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; FEEDER CELL; FIBROBLAST; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL; INNER CELL MASS; MOUSE EMBRYONIC FIBROBLAST; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STEM CELL SELF-RENEWAL; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; MAMMALIAN EMBRYO; METABOLISM; MOUSE;

ANIMALS; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; EMBRYO, MAMMALIAN; FEEDER CELLS; FIBROBLASTS; GLUCOSE; GLYCOLYSIS; HUMAN EMBRYONIC STEM CELLS; HUMANS; MICE; MONOCARBOXYLIC ACID TRANSPORTERS; N-MYC PROTO-ONCOGENE PROTEIN; PLURIPOTENT STEM CELLS; SYMPORTERS;

EID: 84992406226     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2016.08.008     Document Type: Article

References (45)

1. Adijanto, J., Philp, N.J., Chapter Nine - The SLC16A Family of Monocarboxylate Transporters (MCTs)—Physiology and Function in Cellular Metabolism, pH Homeostasis, and Fluid Transport. Bevensee, M.O., (eds.) Current Topics in Membranes, 2012, Academic Press, 275–312.
2. Carbognin, E., Betto, R.M., Soriano, M.E., Smith, A.G., Martello, G., Stat3 promotes mitochondrial transcription and oxidative respiration during maintenance and induction of naive pluripotency. EMBO J. 35 (2016), 618–634.
3. Chambers, S.M., Fasano, C.A., Papapetrou, E.P., Tomishima, M., Sadelain, M., Studer, L., Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27 (2009), 275–280.
4. Chan, Y.-S., Göke, J., Ng, J.-H., Lu, X., Gonzales, K.A.U., Tan, C.-P., Tng, W.-Q., Hong, Z.-Z., Lim, Y.-S., Ng, H.-H., Induction of a human pluripotent state with distinct regulatory circuitry that resembles preimplantation epiblast. Cell Stem Cell 13 (2013), 663–675.
5. Chung, S., Arrell, D.K., Faustino, R.S., Terzic, A., Dzeja, P.P., Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation. J. Mol. Cell. Cardiol. 48 (2010), 725–734.
6. Doherty, J.R., Yang, C., Scott, K.E.N., Cameron, M.D., Fallahi, M., Li, W., Hall, M.A., Amelio, A.L., Mishra, J.K., Li, F., et al. Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis. Cancer Res. 74 (2014), 908–920.
7. Eden, E., Navon, R., Steinfeld, I., Lipson, D., Yakhini, Z., GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics, 10, 2009, 48.
8. Folmes, C.D.L., Nelson, T.J., Martinez-Fernandez, A., Arrell, D.K., Lindor, J.Z., Dzeja, P.P., Ikeda, Y., Perez-Terzic, C., Terzic, A., Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab. 14 (2011), 264–271.
9. Folmes, C.D.L., Nelson, T.J., Dzeja, P.P., Terzic, A., Energy metabolism plasticity enables stemness programs. Ann. N Y Acad. Sci. 1254 (2012), 82–89.
10. Folmes, C.D., Arrell, D.K., Zlatkovic-Lindor, J., Martinez-Fernandez, A., Perez-Terzic, C., Nelson, T.J., Terzic, A., Metabolome and metaboproteome remodeling in nuclear reprogramming. Cell Cycle 12 (2013), 2355–2365.
11. Folmes, C.D.L., Martinez-Fernandez, A., Faustino, R.S., Yamada, S., Perez-Terzic, C., Nelson, T.J., Terzic, A., Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells. J. Cardiovasc. Transl. Res. 6 (2013), 10–21.
12. Gafni, O., Weinberger, L., Mansour, A.A., Manor, Y.S., Chomsky, E., Ben-Yosef, D., Kalma, Y., Viukov, S., Maza, I., Zviran, A., et al. Derivation of novel human ground state naive pluripotent stem cells. Nature 504 (2013), 282–286.
13. Gardner, D.K., Wale, P.L., Collins, R., Lane, M., Glucose consumption of single post-compaction human embryos is predictive of embryo sex and live birth outcome. Hum. Reprod. 26 (2011), 1981–1986.
14. Gustafson, W.C., Meyerowitz, J.G., Nekritz, E.A., Chen, J., Benes, C., Charron, E., Simonds, E.F., Seeger, R., Matthay, K.K., Hertz, N.T., et al. Drugging MYCN through an allosteric transition in Aurora kinase A. Cancer Cell 26 (2014), 414–427.
15. Locasale, J.W., Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat. Rev. Cancer 13 (2013), 572–583.
16. Lu, J., Hou, R., Booth, C.J., Yang, S.-H., Snyder, M., Defined culture conditions of human embryonic stem cells. Proc. Natl. Acad. Sci. USA 103 (2006), 5688–5693.
17. Marks, H., Kalkan, T., Menafra, R., Denissov, S., Jones, K., Hofemeister, H., Nichols, J., Kranz, A., Stewart, A.F., Smith, A., Stunnenberg, H.G., The transcriptional and epigenomic foundations of ground state pluripotency. Cell 149 (2012), 590–604.
18. Niakan, K.K., Eggan, K., Analysis of human embryos from zygote to blastocyst reveals distinct gene expression patterns relative to the mouse. Dev. Biol. 375 (2013), 54–64.
19. Nichols, J., Smith, A., Naive and primed pluripotent states. Cell Stem Cell 4 (2009), 487–492.
20. Osafune, K., Caron, L., Borowiak, M., Martinez, R.J., Fitz-Gerald, C.S., Sato, Y., Cowan, C.A., Chien, K.R., Melton, D.A., Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 26 (2008), 313–315.
21. Pastor, W.A., Chen, D., Liu, W., Kim, R., Sahakyan, A., Lukianchikov, A., Plath, K., Jacobsen, S.E., Clark, A.T., Naive Human Pluripotent Cells Feature a Methylation Landscape Devoid of Blastocyst or Germline Memory. Cell Stem Cell 18 (2016), 323–329.
22. Peiffer, I., Barbet, R., Zhou, Y.-P., Li, M.-L., Monier, M.-N., Hatzfeld, A., Hatzfeld, J.A., Use of xenofree matrices and molecularly-defined media to control human embryonic stem cell pluripotency: effect of low physiological TGF-β concentrations. Stem Cells Dev. 17 (2008), 519–533.
23. Petropoulos, S., Edsgärd, D., Reinius, B., Deng, Q., Panula, S.P., Codeluppi, S., Plaza Reyes, A., Linnarsson, S., Sandberg, R., Lanner, F., Single-Cell RNA-Seq Reveals Lineage and X Chromosome Dynamics in Human Preimplantation Embryos. Cell 165 (2016), 1012–1026.
24. Polański, R., Hodgkinson, C.L., Fusi, A., Nonaka, D., Priest, L., Kelly, P., Trapani, F., Bishop, P.W., White, A., Critchlow, S.E., et al. Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer. Clin. Cancer Res. 20 (2014), 926–937.
25. Prigione, A., Fauler, B., Lurz, R., Lehrach, H., Adjaye, J., The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 28 (2010), 721–733.
26. Rabinowitz, J.D., Vastag, L., Teaching the design principles of metabolism. Nat. Chem. Biol. 8 (2012), 497–501.
27. Rajala, K., Lindroos, B., Hussein, S.M., Lappalainen, R.S., Pekkanen-Mattila, M., Inzunza, J., Rozell, B., Miettinen, S., Narkilahti, S., Kerkelä, E., et al. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS ONE, 5, 2010, e10246.
28. Roode, M., Blair, K., Snell, P., Elder, K., Marchant, S., Smith, A., Nichols, J., Human hypoblast formation is not dependent on FGF signalling. Dev. Biol. 361 (2012), 358–363.
29. Smith, K.N., Singh, A.M., Dalton, S., Myc represses primitive endoderm differentiation in pluripotent stem cells. Cell Stem Cell 7 (2010), 343–354.
30. Sperber, H., Mathieu, J., Wang, Y., Ferreccio, A., Hesson, J., Xu, Z., Fischer, K.A., Devi, A., Detraux, D., Gu, H., et al. The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition. Nat. Cell Biol. 17 (2015), 1523–1535.
31. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., Mesirov, J.P., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102 (2005), 15545–15550.
32. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006), 663–676.
33. Takashima, Y., Guo, G., Loos, R., Nichols, J., Ficz, G., Krueger, F., Oxley, D., Santos, F., Clarke, J., Mansfield, W., et al. Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell 158 (2014), 1254–1269.
34. Thai, M., Graham, N.A., Braas, D., Nehil, M., Komisopoulou, E., Kurdistani, S.K., McCormick, F., Graeber, T.G., Christofk, H.R., Adenovirus E4ORF1-induced MYC activation promotes host cell anabolic glucose metabolism and virus replication. Cell Metab. 19 (2014), 694–701.
35. Theunissen, T.W., Powell, B.E., Wang, H., Mitalipova, M., Faddah, D.A., Reddy, J., Fan, Z.P., Maetzel, D., Ganz, K., Shi, L., et al. Systematic identification of culture conditions for induction and maintenance of naive human pluripotency. Cell Stem Cell 15 (2014), 471–487.
36. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., Jones, J.M., Embryonic stem cell lines derived from human blastocysts. Science 282 (1998), 1145–1147.
37. Valamehr, B., Robinson, M., Abujarour, R., Rezner, B., Vranceanu, F., Le, T., Medcalf, A., Lee, T.T., Fitch, M., Robbins, D., Flynn, P., Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells. Stem Cell Reports 2 (2014), 366–381.
38. Varum, S., Rodrigues, A.S., Moura, M.B., Momcilovic, O., Easley, C.A. 4th, Ramalho-Santos, J., Van Houten, B., Schatten, G., Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS ONE, 6, 2011, e20914.
39. Vassena, R., Boué, S., González-Roca, E., Aran, B., Auer, H., Veiga, A., Izpisua Belmonte, J.C., Waves of early transcriptional activation and pluripotency program initiation during human preimplantation development. Development 138 (2011), 3699–3709.
40. Ware, C.B., Nelson, A.M., Mecham, B., Hesson, J., Zhou, W., Jonlin, E.C., Jimenez-Caliani, A.J., Deng, X., Cavanaugh, C., Cook, S., et al. Derivation of naive human embryonic stem cells. Proc. Natl. Acad. Sci. USA 111 (2014), 4484–4489.
41. Yan, L., Yang, M., Guo, H., Yang, L., Wu, J., Li, R., Liu, P., Lian, Y., Zheng, X., Yan, J., et al. Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells. Nat. Struct. Mol. Biol. 20 (2013), 1131–1139.
42. Yoshida, Y., Takahashi, K., Okita, K., Ichisaka, T., Yamanaka, S., Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5 (2009), 237–241.
43. Zhang, J., Khvorostov, I., Hong, J.S., Oktay, Y., Vergnes, L., Nuebel, E., Wahjudi, P.N., Setoguchi, K., Wang, G., Do, A., et al. UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J. 30 (2011), 4860–4873.
44. Zhang, J., Nuebel, E., Daley, G.Q., Koehler, C.M., Teitell, M.A., Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal. Cell Stem Cell 11 (2012), 589–595.
45. Zhou, W., Choi, M., Margineantu, D., Margaretha, L., Hesson, J., Cavanaugh, C., Blau, C.A., Horwitz, M.S., Hockenbery, D., Ware, C., Ruohola-Baker, H., HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition. EMBO J. 31 (2012), 2103–2116.